Terson syndrome

Last updated
Terson syndrome
Eyesection.svg
Eye anatomy (vitreous humor indicated)
Specialty Ophthalmology

Terson syndrome or Terson's syndrome is a condition where eye haemorrhages occur due to intracranial bleeding, most often associated with subarachnoid haemorrhage (SAH), commonly from a ruptured cerebral aneurysm. Patients may experience blurred vision, floaters, or complete vision loss due to retinal or vitreous haemorrhage, and neurological symptoms like severe headaches, nausea, seizures, and confusion may also arise. Diagnosis is challenging as the eye bleeding can resemble other conditions, such as diabetic retinopathy or retinal vein occlusion. A fundoscopic exam is the primary diagnostic method, but imaging like CT, MRI, and OCT can aid in confirming the diagnosis. Treatment involves managing intracranial pressure and haemorrhage, with options like vitrectomy or anti-VEGF injections for persistent eye bleeds. The prognosis depends on the severity of both neurological and ocular damage, with early intervention improving recovery chances. However, recurrence risks exist depending on the underlying cause of the haemorrhage. Research continues on improving early diagnosis, surgical approaches, and understanding the genetic and molecular factors influencing the disease. [1]

Contents

History

An instance of intraretinal hemorrhage coexisting with subarachnoid hemorrhage (SAH) was initially documented by German ophthalmologist Moritz Litten in 1881. In 1900, French ophthalmologist Albert Terson reported a link between SAH—later known as Terson syndrome—and vitreous hemorrhage. This syndrome includes many kinds of intraocular hemorrhages, usually caused by a sudden increase in intracranial pressure (ICP), which can happen in combination with SAH, intracerebral hemorrhage, or traumatic brain injury.

The vitreous, sub-hyaloid, subretinal space, intraretinal regions, or beneath the internal limiting membrane are some of the locations where the hemorrhages may occur in the eye. According to Sohan Hayreh, the rupture of capillaries in the optic nerve, which is most likely brought on by elevated retinal venous pressure from central retinal vein compression, is the source of these retinal hemorrhages. The intricate vascular connections between the brain and the eye are highlighted by the fact that Terson syndrome is most frequently observed after aneurysmal subarachnoid hemorrhages. This emphasizes how crucial it is to diagnose and treat the illness using a thorough, interdisciplinary approach. Terson syndrome occurs in about 13% of SAH patients, especially in more severe instances (shown by a higher Hunt-Hess score), and these cases are linked to a higher risk of death. Persistent vision impairment can cause problems carrying out daily tasks, which might lower one's quality of life or cause psychological suffering like anxiety or depression. In certain instances, vision may return to almost normal levels as the blood in the eye gradually clears itself without the need for major treatment. However, depending on how severe the initial bleeding was, this procedure may take weeks or months.

Signs and symptoms

Temporary Terson's Syndrome symptoms and indicators include abrupt vision loss or blurred vision in one or both eyes, being the most obvious signs of Terson's syndrome. The reason behind this is that blood in the vitreous or retinal layers blocks light from reaching the retina. The extent and location of the intraocular hemorrhage determine the degree of vision impairment. Because of clots or debris in the vitreous cavity, patients may suffer floaters, which are spots or threads in their field of vision. In extreme situations, extensive vitreous bleeding may result in a total loss of the red reflex. Patients frequently exhibit signs of Terson's syndrome because the illness frequently coexists with cerebral hemorrhages such as subarachnoid hemorrhage (SAH). These could include a severe headache (referred to as a "thunderclap headache" in situations of SAH), nausea and vomiting, changed mental status or confusion, and stiff neck (caused by meningism connected to SAH). The symptoms and indicators of Terson's syndrome that persist throughout time are Long-term vision impairments may result if the intraocular hemorrhage is not treated or resorbed naturally. These could include irreversible vision loss, particularly in cases of retinal detachment or macula damage. Retinal fibrosis or tractional retinal detachment can result from persistent, untreated intraocular bleeding. This scarring may necessitate surgery and significantly compromise vision. The fact that Terson's illness mostly affects the brain and eyes highlights the intimate relationship between intracranial pressure and ocular structures. Intraocular bleeding, which can happen in the retina, subhyaloid space (beyond the vitreous membrane), or vitreous body, is the main cause of ocular involvement. If treatment is not received, this bleeding can cause long-term problems such retinal detachment or scarring in addition to impairing eyesight.

The underlying pathology originates in the brain and usually involves an intracranial hemorrhage, such as a subarachnoid hemorrhage (SAH), or several types of elevated intracranial pressure. The abrupt increase in intracranial pressure causes the condition, which is then communicated to the eyes through the optic nerve sheath. Furthermore, symptoms like headaches, nausea, or neurological abnormalities resulting from the main intracranial trauma may be caused by the syndrome's indirect impact on neurological function. The significance of a comprehensive approach to diagnosis and therapy is underscored by these interrelated effects, which show how systemic illnesses can appear in localized areas like the eyes.

Causes

It appears as an aftereffect of an intracranial hemorrhage (such as traumatic brain injury or subarachnoid hemorrhage). Intraocular bleeding results from the condition's abrupt and severe rise in intracranial pressure, which is then conveyed to the eyes through the optic nerve sheath. Terson's syndrome's most frequent cause. A ruptured cerebral aneurysm is usually the cause of SAH, which can result in visual problems and elevated intracranial pressure. An increased risk of Terson's syndrome can result from severe head trauma that causes intracranial bleeding. elevated intracranial pressure brought on by diseases such as brain tumors, arteriovenous malformations, or extreme hypertension.

Standard diagnostic criteria and methods

Terson's syndrome is frequently diagnosed by combining neurological and ophthalmological testing. Fundoscopy, which enables direct evaluation of the retina for indications of bleeding, usually in the vitreous or retinal areas, is the main diagnostic technique. Further confirmation of intraocular and cerebral hemorrhages can be obtained using further imaging modalities. Ocular ultrasonography can be used to evaluate the anatomy of the eye when the hemorrhage prevents retinal vision. Terson's syndrome is characterized by hemorrhages beneath the internal limiting membrane, which can be detected by optical coherence tomography (OCT).

Despite being uncommon, fluorescein angiography may be useful in assessing retinal blood flow and detecting issues. To verify whether brain hemorrhages are present, neurological imaging is essential. In order to identify subarachnoid hemorrhage and other forms of cerebral bleeding, a CT scan is frequently the initial step. While MRA or CTA (magnetic resonance or computed tomography angiography) can be useful in identifying vascular abnormalities, such as aneurysms, that may have contributed to the hemorrhage, MRI can offer better detailed imaging of mild brain hemorrhages. An important diagnostic criterion is the temporal correlation between the cerebral hemorrhage and the commencement of ocular bleeding; because of increased intracranial pressure, the eye hemorrhage usually happens soon after the brain bleed.

Other diagnostic assessments include visual acuity tests to measure the impact on vision and lumbar puncture to confirm subarachnoid hemorrhage when imaging results are unclear. This comprehensive approach ensures that Terson’s syndrome is accurately diagnosed and managed.

Challenges in diagnosis

Due to its symptoms' overlap with those of other eye disorders such diabetic retinopathy, retinal vein occlusion, or hypertensive retinopathy—all of which can result in retinal or vitreous hemorrhages—diagnosing Terson's syndrome can be difficult. If the neurological history of a patient is not carefully taken into account, these similarities may result in a misdiagnosis. Furthermore, during fundoscopy, thick vitreous hemorrhage may obscure the retina, making it challenging to locate the bleeding source. To confirm the intraocular hemorrhage and prevent a delayed diagnosis, further imaging, like as ultrasound, may be required in some situations.

Intraocular hemorrhages may be mild or asymptomatic in certain patients, particularly if the bleeding is not severe. Because these people might not exhibit visual symptoms, medical professionals might simply concentrate on neurological evaluation, ignoring the necessity of an ocular examination. Furthermore, Terson's syndrome is somewhat uncommon and might not be identified right once, especially in non-specialized contexts. Delays in diagnosis and treatment may result from professionals' lack of awareness.

Assessing ocular involvement may be delayed in emergency settings involving patients who have experienced traumatic brain injuries because the focus frequently moves to stabilizing the patient's neurological status. Intraocular hemorrhage can also result from elevated intracranial pressure caused by tumors or brain swelling, but this may go unnoticed if Terson's disease is not diagnosed. In order to treat the neurological and ocular components of the illness and avoid long-term visual impairment, early detection and timely intervention are essential.

Common misdiagnoses

Current treatment options and their effectiveness

Management of intracranial hemorrhage

Observation and monitoring of intraocular hemorrhage

Vitrectomy (surgical removal of vitreous hemorrhage)

Intravitreal anti-VEGF injections

Laser photocoagulation (rarely used)

Ocular rehabilitation and visual aids

Phases

Initial onset

A subarachnoid hemorrhage brought on by a ruptured aneurysm, or less frequently, other forms of brain hemorrhages (such intracerebral or subdural hemorrhages), is usually the origin of the abrupt increase in intracranial pressure that frequently precedes the onset of Turner's syndrome.

This rise in pressure causes intraocular hemorrhage, typically in the retina or vitreous, which causes symptoms including impaired vision, vision loss, or "floaters."

Development of symptoms

Settlement or therapy

Recovery potential

Vision recovery

Neurological recovery

Risk of recurrence

The underlying cause of the original episode has a significant impact on the recurrence of intracranial and intraocular hemorrhages in Terson's syndrome. For instance, the chance of rebleeding is greatly decreased in situations with ruptured aneurysms once the aneurysm is treated using techniques like coiling or clipping. Other factors, such poorly controlled hypertension, could raise the chance of more brain hemorrhages in the future, though. Similarly, if intracranial pressure is regulated, intraocular bleeding from a single brain event usually does not repeat. Recurrent intraocular bleeding, however, may result from any further bouts of elevated intracranial pressure, such as those caused by a fresh or recurrent brain hemorrhage. To reduce the chance of recurrence, the underlying ailment must be well managed.

Factors that influence prognosis

The prognosis for Terson's syndrome is influenced by several factors, including the patient's age, overall health, the severity and location of the intracranial hemorrhage, the timeliness of treatment, and the extent of intraocular hemorrhage. Younger patients generally experience better recovery outcomes due to stronger healing capacities and fewer complications. In contrast, older patients may face a higher risk of complications, such as hypertension, diabetes, and age-related changes in the brain and eyes, which can reduce their recovery potential.

Chronic health conditions like hypertension, diabetes, and cardiovascular disease increase the risk of recurrence and hinder recovery. Healthy vascular and immune systems are essential for healing and blood reabsorption; poor vascular health can lead to slower or incomplete recovery. The severity and location of the intracranial hemorrhage play a significant role in the prognosis, with severe hemorrhages and those in critical brain regions, such as the brainstem, leading to worse outcomes. Elevated intracranial pressure (ICP) exacerbates both neurological and visual complications.

Timely treatment is crucial for improving recovery. Early neurosurgical intervention and prompt ophthalmologic treatment, such as vitrectomy for severe intraocular hemorrhages, can significantly improve both neurological and visual outcomes. Access to specialized care that integrates neurology and ophthalmology expertise is also vital for optimal recovery.

Intraocular hemorrhage severity further affects prognosis. Mild hemorrhages may resolve naturally, but severe, dense hemorrhages, if left untreated, can lead to permanent vision impairment and complications such as retinal detachment. Ongoing rehabilitation and follow-up care are essential to maximize recovery, and lifestyle adjustments—such as controlling blood pressure, managing blood sugar, and avoiding smoking—can improve long-term outcomes and reduce the risk of recurrence.

Epidemiology

Terson syndrome is relatively rare, and exact prevalence and incidence rates remain uncertain due to frequent underreporting, especially in patients with severe intracranial injuries. Estimates suggest that 8-15% of patients with subarachnoid hemorrhage (SAH) develop Terson syndrome, though detection methods and study populations can cause this rate to vary. Terson syndrome (TS) is characterized by intraocular hemorrhage following an intracranial bleed, such as SAH. Reported incidence rates for TS following SAH range from 8% to as high as 46%, depending on the study and patient demographics. In one study, up to 21% of SAH patients were found to have TS. However, the true prevalence may be underestimated due to the high mortality rate linked to SAH and other brain hemorrhages, which can limit the number of patients surviving long enough to receive a diagnosis. Although TS is uncommon, it is most often associated with ruptures of the anterior communicating artery (ACommA) aneurysms.

Demographic variations

Several factors can impact both the frequency and outcomes of Terson syndrome. Terson syndrome can affect individuals of all ages, but it is more commonly observed in middle-aged and older adults, particularly those at an elevated risk for subarachnoid hemorrhage due to aneurysms. While the condition is most frequently reported in adults between the ages of 30 and 60, it can also occur in children, typically following traumatic brain injuries or less common causes like arteriovenous malformations. Pediatric cases tend to have better outcomes, owing to the faster healing capacity of younger individuals, though untreated cases can still lead to permanent visual impairments. In older adults, outcomes are generally poorer due to the prevalence of chronic conditions such as hypertension, diabetes, and cerebrovascular disease, which increase susceptibility to both intracranial and ocular hemorrhages. There is a slight male predominance in Terson syndrome, as seen in studies like one from Policlinico Gemelli in Rome, where 53% of patients were male. This may be attributed to higher rates of aneurysm rupture, which occur more frequently in men, particularly with subarachnoid hemorrhage (SAH). However, women are also affected, with factors such as hormonal changes, pregnancy-related complications, and a higher likelihood of aneurysms in certain areas of the posterior circulation playing a role. Geographically, Terson syndrome is diagnosed worldwide but is more frequently observed in regions with higher rates of subarachnoid hemorrhage, such as North America and Europe, where advanced imaging technologies like CT and MRI improve detection and management. In contrast, regions with limited healthcare resources may experience underreporting of Terson syndrome due to misdiagnosis or lack of diagnostic capabilities, particularly in settings where cerebrovascular diseases and trauma are less comprehensively managed. The scarcity of large-scale data on Terson syndrome underscores the need for further research to better understand its prevalence, risk factors, and outcomes across diverse populations.

Research directions

Improved early diagnosis

Surgical advances in treatment

Pathophysiology and genetic factors

Long-term prognosis and rehabilitation

Predictive models and risk stratification

Related Research Articles

<span class="mw-page-title-main">Cerebral arteriovenous malformation</span> Abnormal connection between the arteries and veins in the brain

A cerebral arteriovenous malformation is an abnormal connection between the arteries and veins in the brain—specifically, an arteriovenous malformation in the cerebrum.

<span class="mw-page-title-main">Head injury</span> Serious trauma to the cranium

A head injury is any injury that results in trauma to the skull or brain. The terms traumatic brain injury and head injury are often used interchangeably in the medical literature. Because head injuries cover such a broad scope of injuries, there are many causes—including accidents, falls, physical assault, or traffic accidents—that can cause head injuries.

<span class="mw-page-title-main">Papilledema</span> Swelling of the eyes optic disc due to high intracranial pressure

Papilledema or papilloedema is optic disc swelling that is caused by increased intracranial pressure due to any cause. The swelling is usually bilateral and can occur over a period of hours to weeks. Unilateral presentation is extremely rare.

<span class="mw-page-title-main">Intracranial aneurysm</span> Ballooning or rupturing of a blood vessel in the brain

An intracranial aneurysm, also known as a cerebral aneurysm, is a cerebrovascular disorder characterized by a localized dilation or ballooning of a blood vessel in the brain due to a weakness in the vessel wall. These aneurysms can occur in any part of the brain but are most commonly found in the arteries of the cerebral arterial circle. The risk of rupture varies with the size and location of the aneurysm, with those in the posterior circulation being more prone to rupture.

<span class="mw-page-title-main">Cerebrovascular disease</span> Condition that affects the arteries that supply the brain

Cerebrovascular disease includes a variety of medical conditions that affect the blood vessels of the brain and the cerebral circulation. Arteries supplying oxygen and nutrients to the brain are often damaged or deformed in these disorders. The most common presentation of cerebrovascular disease is an ischemic stroke or mini-stroke and sometimes a hemorrhagic stroke. Hypertension is the most important contributing risk factor for stroke and cerebrovascular diseases as it can change the structure of blood vessels and result in atherosclerosis. Atherosclerosis narrows blood vessels in the brain, resulting in decreased cerebral perfusion. Other risk factors that contribute to stroke include smoking and diabetes. Narrowed cerebral arteries can lead to ischemic stroke, but continually elevated blood pressure can also cause tearing of vessels, leading to a hemorrhagic stroke.

<span class="mw-page-title-main">Vitrectomy</span> Surgery to remove vitreous humor from the eye

Vitrectomy is a surgery to remove some or all of the vitreous humor from the eye.

<span class="mw-page-title-main">Subarachnoid hemorrhage</span> Bleeding into the brains subarachnoid space

Subarachnoid hemorrhage (SAH) is bleeding into the subarachnoid space—the area between the arachnoid membrane and the pia mater surrounding the brain. Symptoms may include a severe headache of rapid onset, vomiting, decreased level of consciousness, fever, weakness, numbness, and sometimes seizures. Neck stiffness or neck pain are also relatively common. In about a quarter of people a small bleed with resolving symptoms occurs within a month of a larger bleed.

<span class="mw-page-title-main">Subdural hematoma</span> Hematoma usually associated with traumatic brain injury

A subdural hematoma (SDH) is a type of bleeding in which a collection of blood—usually but not always associated with a traumatic brain injury—gathers between the inner layer of the dura mater and the arachnoid mater of the meninges surrounding the brain. It usually results from tears in bridging veins that cross the subdural space.

<span class="mw-page-title-main">Intracranial hemorrhage</span> Hemorrhage, or bleeding, within the skull

Intracranial hemorrhage (ICH), also known as intracranial bleed, is bleeding within the skull. Subtypes are intracerebral bleeds, subarachnoid bleeds, epidural bleeds, and subdural bleeds.

A thunderclap headache is a headache that is severe and has a sudden onset. It is defined as a severe headache that takes seconds to minutes to reach maximum intensity. Although approximately 75% are attributed to "primary" headaches—headache disorder, non-specific headache, idiopathic thunderclap headache, or uncertain headache disorder—the remainder are secondary to other causes, which can include some extremely dangerous acute conditions, as well as infections and other conditions. Usually, further investigations are performed to identify the underlying cause.

Retinal hemorrhage is a disorder of the eye in which bleeding occurs in the retina, the light sensitive tissue, located on the back wall of the eye. There are photoreceptor cells in the retina called rods and cones, which transduce light energy into nerve signals that can be processed by the brain to form visual images. Retinal hemorrhage is strongly associated with child abuse in infants and young children and often leaves such abused infants permanently blind. In older children and adults, retinal hemorrhage can be caused by several medical conditions such as hypertension, retinal vein occlusion, anemia, leukemia or diabetes.

<span class="mw-page-title-main">Intracerebral hemorrhage</span> Type of intracranial bleeding that occurs within the brain tissue itself

Intracerebral hemorrhage (ICH), also known as hemorrhagic stroke, is a sudden bleeding into the tissues of the brain, into its ventricles, or into both. An ICH is a type of bleeding within the skull and one kind of stroke. Symptoms can vary dramatically depending on the severity, acuity, and location (anatomically) but can include headache, one-sided weakness, numbness, tingling, or paralysis, speech problems, vision or hearing problems, memory loss, attention problems, coordination problems, balance problems, dizziness or lightheadedness or vertigo, nausea/vomiting, seizures, decreased level of consciousness or total loss of consciousness, neck stiffness, and fever.

<span class="mw-page-title-main">Intraparenchymal hemorrhage</span> Bleeding within parenchymal tissue of the brain

Intraparenchymal hemorrhage is one form of intracerebral bleeding in which there is bleeding within brain parenchyma. The other form is intraventricular hemorrhage).

<span class="mw-page-title-main">Epiretinal membrane</span> Eye disease

Epiretinal membrane or macular pucker is a disease of the eye in response to changes in the vitreous humor or more rarely, diabetes. Sometimes, as a result of immune system response to protect the retina, cells converge in the macular area as the vitreous ages and pulls away in posterior vitreous detachment (PVD).

<span class="mw-page-title-main">Intraocular hemorrhage</span> Medical condition

Intraocular hemorrhage is bleeding inside the eye. Bleeding can occur from any structure of the eye where there is vasculature or blood flow, including the anterior chamber, vitreous cavity, retina, choroid, suprachoroidal space, or optic disc.

<span class="mw-page-title-main">Persistent fetal vasculature</span> Medical condition

Persistent fetal vasculature(PFV), also known as persistent fetal vasculature syndrome (PFVS), and until 1997 known primarily as persistent hyperplastic primary vitreous (PHPV), is a rare congenital anomaly which occurs when blood vessels within the developing eye, known as the embryonic hyaloid vasculature network, fail to regress as they normally would in-utero after the eye is fully developed. Defects which arise from this lack of vascular regression are diverse; as a result, the presentation, symptoms, and prognosis of affected patients vary widely, ranging from clinical insignificance to irreversible blindness. The underlying structural causes of PFV are considered to be relatively common, and the vast majority of cases do not warrant additional intervention. When symptoms do manifest, however, they are often significant, causing detrimental and irreversible visual impairment. Persistent fetal vasculature heightens the lifelong risk of glaucoma, cataracts, intraocular hemorrhages, and Retinal detachments, accounting for the visual loss of nearly 5% of the blind community in the developed world. In diagnosed cases of PFV, approximately 90% of patients with a unilateral disease have associated poor vision in the affected eye.

<span class="mw-page-title-main">Bonnet–Dechaume–Blanc syndrome</span> Medical condition

Bonnet–Dechaume–Blanc syndrome, also known as Wyburn-Mason syndrome, is a rare congenital disorder characterized by arteriovenous malformations of the brain, retina or facial nevi. The syndrome has a number of possible symptoms and can, more rarely, affect the skin, bones, kidneys, muscles, and gastrointestinal tract. When the syndrome affects the brain, people can experience severe headaches, seizures, acute stroke, meningism, and progressive neurological deficits due to acute or chronic ischaemia caused by arteriovenous shunting.

<span class="mw-page-title-main">Vitreous hemorrhage</span> Leakage of blood into the internal fluid of the eye

Vitreous hemorrhage is the extravasation, or leakage, of blood into the areas in and around the vitreous humor of the eye. The vitreous humor is the clear gel that fills the space between the lens and the retina of the eye. A variety of conditions can result in blood leaking into the vitreous humor, which can cause impaired vision, floaters, and photopsia.

<span class="mw-page-title-main">Cerebroretinal microangiopathy with calcifications and cysts</span> Medical condition

Cerebroretinal microangiopathy with calcifications and cysts (CRMCC) is a rare genetic disorder, which affects multiple organs. Its hallmarks are widespread progressive calcifications, cysts and abnormalities of the white matter of the brain, usually occurring together with abnormalities of the blood vessels of the retina. Additional features include poor prenatal growth, preterm birth, anemia, osteopenia and bone fractures, and gastrointestinal bleeding. It is caused by compound heterozygous mutations in the conserved telomere maintenance component 1 (CTC1) gene, but its exact pathophysiology is still not well understood.

Valsalva retinopathy is a form of retinopathy due to retinal bleeding secondary to rupture of retinal vessels caused by intrathoracic or intra-abdominal pressure due to physical activities.

References

  1. "Terson Syndrome - EyeWiki".
  2. Minnella, Angelo Maria; MacEroni, Martina; Caputo, Carmela Grazia; Sasso, Paola; Verardi, Gabriele; De Simone, Danio; Ciasca, Gabriele; Rizzo, Stanislao; Buzzi, Maria Gabriella; Della Vedova, Cecilia; Formisano, Rita (2024). "Management of Terson Syndrome: Long-Term Experience in a Single Center". Biomedicines. 12 (10): 2336. doi: 10.3390/biomedicines12102336 . PMC   11505554 . PMID   39457648.
  3. Minnella, Angelo Maria; MacEroni, Martina; Caputo, Carmela Grazia; Sasso, Paola; Verardi, Gabriele; De Simone, Danio; Ciasca, Gabriele; Rizzo, Stanislao; Buzzi, Maria Gabriella; Della Vedova, Cecilia; Formisano, Rita (2024). "Management of Terson Syndrome: Long-Term Experience in a Single Center". Biomedicines. 12 (10): 2336. doi: 10.3390/biomedicines12102336 . PMC   11505554 . PMID   39457648.
  4. "Terson Syndrome | American Journal of Neuroradiology".
  5. "Terson Syndrome | American Journal of Neuroradiology".
  6. "Terson Syndrome | American Journal of Neuroradiology".
  7. Minnella, Angelo Maria; MacEroni, Martina; Caputo, Carmela Grazia; Sasso, Paola; Verardi, Gabriele; De Simone, Danio; Ciasca, Gabriele; Rizzo, Stanislao; Buzzi, Maria Gabriella; Della Vedova, Cecilia; Formisano, Rita (2024). "Management of Terson Syndrome: Long-Term Experience in a Single Center". Biomedicines. 12 (10): 2336. doi: 10.3390/biomedicines12102336 . PMC   11505554 . PMID   39457648.
  8. Minnella, Angelo Maria; MacEroni, Martina; Caputo, Carmela Grazia; Sasso, Paola; Verardi, Gabriele; De Simone, Danio; Ciasca, Gabriele; Rizzo, Stanislao; Buzzi, Maria Gabriella; Della Vedova, Cecilia; Formisano, Rita (2024). "Management of Terson Syndrome: Long-Term Experience in a Single Center". Biomedicines. 12 (10): 2336. doi: 10.3390/biomedicines12102336 . PMC   11505554 . PMID   39457648.